Chemical Peritonitis After Intraperitoneal Sodium Thiosulfate

1. Diaz–Buxo JA. Management of peritoneal catheter malfunction. Perit Dial Int 1998; 18:256–9. 2. Yilmazlar T, Kirdak T, Bilgin S, Yavuz M, Yurtkuran M. Laparoscopic findings of peritoneal dialysis catheter malfunction and management outcomes. Perit Dial Int 2006; 26:374–9. 3. Rosenthal MA, Yang PS, Liu IL, Sim JJ, Kujubu DA, Rasgon SA, et al. Comparison of outcomes of peritoneal dialysis catheters placed by the fluoroscopically guided percutaneous method versus directly visualized surgical method. J Vasc Interv radiol 2008; 19:1202–7. 4. Kappel JE, Ferguson GM, Kudel RM, Kudel TA, Lawlor BJ, Pylypchuk GB. Stiff wire manipulation of peritoneal dialysis catheters. adv Perit Dial 1995; 11:202–7. 5. Diaz–Buxo JA, Turner MW, Nelms M. Fluoroscopic manipulation of Tenckhoff catheters: outcome analysis. clin Nephrol 1997; 47:384–8. 6. Simons ME, Pron G, Voros M, Vanderburgh LC, Rao PS, Oreopoulos DG. Fluoroscopically-guided manipulation of malfunctioning peritoneal dialysis catheters. Perit Dial Int 1999; 19:544–9. 7. Kazory A, Cendan JC, Hollen TL, Ross EA. Primary malfunction of a peritoneal dialysis catheter due to encasement in an encapsulating sheath. Perit Dial Int 2007; 27:707–9. 8. Besarab A, Pandey R. Catheter management in hemodialysis patients: delivering adequate flow. clin J am Soc Nephrol 2011; 6:227–34. 9. Dwyer A. Surface-treated catheters—a review. Semin Dial 2008; 21:542–6. 10. Gries E, Paar D, Graben N, Bock KD. Intraperitoneal fibrinformation and its inhibition in CAPD. clin Nephrol 1986; 26:209–12. 11. Tabata T, Shimada H, Emoto M, Morita A, Furumitsu Y, Fujita J, et al. Inhibitory effect of heparin and/or antithrombin III on intraperitoneal fibrin formation in continuous ambulatory peritoneal dialysis. Nephron 1990; 56:391–5. doi:10.3747/pdi.2011.00172

[1]  A. Besarab,et al.  Catheter management in hemodialysis patients: delivering adequate flow. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[2]  J. Zechlinski,et al.  Calciphylaxis in the Absence of Renal Disease: Secondary Hyperparathyroidism and Systemic Lupus Erythematosus , 2009, The Journal of Rheumatology.

[3]  M. McAleer,et al.  Calciphylaxis in a patient with normal renal function: response to treatment with sodium thiosulfate , 2009, Clinical and experimental dermatology.

[4]  Amy C. Dwyer.  Surface‐Treated Catheters—A Review , 2008, Seminars in dialysis.

[5]  C. Raymond,et al.  Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. , 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[6]  I. Liu,et al.  Comparison of outcomes of peritoneal dialysis catheters placed by the fluoroscopically guided percutaneous method versus directly visualized surgical method. , 2008, Journal of vascular and interventional radiology : JVIR.

[7]  M. Wolf,et al.  Calciphylaxis from nonuremic causes: a systematic review. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[8]  A. Fine,et al.  Calciphylaxis: The Beginning of the End? , 2008, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[9]  J. Sowers,et al.  Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate , 2008, International Urology and Nephrology.

[10]  J. Cendan,et al.  Primary Malfunction of a Peritoneal Dialysis Catheter Due to Encasement in an Encapsulating Sheath , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[11]  G. Saab,et al.  Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[12]  M. Drezner,et al.  Calciphylaxis in the absence of end-stage renal disease. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[13]  M. Yurtkuran,et al.  Laparoscopic Findings of Peritoneal Dialysis Catheter Malfunction and Management Outcomes , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[14]  B. Bastani,et al.  Intraperitoneal Sodium Thiosulfate for the Treatment of Calciphylaxis , 2006, Renal failure.

[15]  D. Spector,et al.  Successful treatment of calciphylaxis with intravenous sodium thiosulfate. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  C. Magro,et al.  Calciphylaxis: Emerging Concepts in Prevention, Diagnosis, and Treatment , 2002, Seminars in dialysis.

[17]  F. Cosio,et al.  Transcutaneous oxygen tension in patients with calciphylaxis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  P. Rao,et al.  Fluoroscopically-Guided Manipulation of Malfunctioning Peritoneal Dialysis Catheters , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[19]  Jose A. Diaz-Buxo.  Management of Peritoneal Catheter Malfunction , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[20]  S. Myers,et al.  Calciphylaxis in patients on hemodialysis: a prevalence study. , 1997, Surgery.

[21]  J. Díaz-Buxó,et al.  Fluoroscopic manipulation of Tenckhoff catheters: outcome analysis. , 1997, Clinical Nephrology.

[22]  J. Kappel,et al.  Stiff wire manipulation of peritoneal dialysis catheters. , 1995, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[23]  T. Tabata,et al.  Inhibitory effect of heparin and/or antithrombin III on intraperitoneal fibrin formation in continuous ambulatory peritoneal dialysis. , 1990, Nephron.

[24]  D. Paár,et al.  Intraperitoneal fibrin-formation and its inhibition in CAPD. , 1986, Clinical Nephrology.